UFC officials today answered the question Vitor Belfort refused to address: Yes, "The Phenom" did use testosterone replacement therapy in advance of his UFC on FX 7 win over Michael Bisping.
UFC officials today revealed Belfort was granted a therapeutic-use exemption for testosterone replacement therapy prior to the bout and that his post-fight drug screen "did not indicate the presence of any prohibited substance for increasing performance improvement."
Belfort and Bisping headlined the Jan. 19 event, which took place at Sao Paulo's Ibirapuera Gymnasium. The Brazilian scored a second-round TKO over the Brit and then proceeded to call for a rematch with current light heavyweight champion Jon Jones.
All 22 fighters who competed on the card were tested for performance-enhancing drugs and drugs of abuse, and the UFC this past week confirmed one test result in an "irregular" finding, which led to speculation that Belfort – who in 2006 was suspended by the Nevada State Athletic Commission after testing positive for the anabolic steroid 4-Hydroxytestosterone – was the culprit.LINK